CIAM
AEON icon

Caitong International Asset Management’s AEON Biopharma AEON Stock Holding History

Caitong International Asset Management’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Buy
+1
New +$1 ﹤0.01% 2454

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Caitong International Asset Management's AEON Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in AEON Biopharma (AEON) in Q1 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #2454 among its holdings.

24 funds tracked by Wall St. Rank hold AEON as of Q1 2026.

  • Caitong International Asset Management held 1 share of AEON Biopharma worth $1 as of Q1 2026.
  • AEON Biopharma was a new Caitong International Asset Management position in Q1 2026.
  • AEON Biopharma made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2454 holding.
  • 24 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.